Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

The medication, known as a “polypill,” includes three active ingredients (acetylsalicylic acid, ramipril, and atorvastatin)

News | Nuclear Imaging

World Health Organization Includes the Cardiovascular Polypill in its list of Essential Medicines after a Groundbreaking Study Led by the President of Mount Sinai Heart

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

August 03, 2023

Merit’s WAVE study is a prospective, randomized, controlled, multicenter study

News | Cardiovascular Clinical Studies

Merit Medical’s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

August 3, 2023 — Merit Medical Systems, a leading global manufacturer and marketer of healthcare technology, today ...

August 03, 2023

India clinical trial commences with first 30 cases

News | Heart Valve Technology

First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 — Foldax , Inc., a leader in the development of innovative, polymer heart valves, today announced that ...

August 02, 2023

LX2020 preclinical studies demonstrated proof-of-concept with treatment restoring desmosomal integrity, reducing arrhythmias, and extending survival in a clinically relevant murine model

News | Pharmaceuticals

LEXEO Therapeutics Announces FDA Clearance of IND for LX2020, an AAV-based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

August 01, 2023

AI demonstrated high accuracy, reduced non-diagnostic outputs, and identified HFpEF patients with worse outcomes.

News | Cardiovascular Clinical Studies

Study Confirms Ultromics' AI Can Improve HFpEF Detection Using a Single Echocardiogram View

July 31, 2023 — Applying AI to a single apical four chamber (A4C) view echocardiogram provides accurate information to ...

July 31, 2023

Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making

News | Cardiovascular Clinical Studies

HeartFlow to Announce New Data at SCCT23

July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy ...

July 28, 2023

A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).

News | Cardiovascular Clinical Studies

Large PCORI Award Funds Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations

July 25, 2023 — A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss ...

July 25, 2023

BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP Cell Therapy Heart Failure Trial

News | Cardiovascular Clinical Studies

BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected

July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

July 24, 2023

SmartfIRE study is evaluating THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safe and simple procedures with the ability to deliver both radiofrequency (RF) and pulsed field ablation (PFA)

News | Atrial Fibrillation

Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe

July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

July 21, 2023

Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience

News | Remote Monitoring

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

July 21, 2023 — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today ...

July 21, 2023

Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients

News | Stroke

First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment

July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...

July 20, 2023

The proposed approach outperforms other neural network architectures by leveraging rich geometric information to segment brain stroke lesion images

News | Stroke

New Geometric Deep Learning Model for Detecting Stroke Lesions

July 19, 2023 — Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the ...

July 19, 2023

A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention

News | Artificial Intelligence

AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

July 18, 2023

No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB

News | Drug-Eluting Balloons

BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

July 14, 2023

Illustration for the deployment and shaping process of the occluder.

News | Structural Heart Occluders

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

July 14, 2023